Non-invasive dynamic near-infrared imaging and quantification of vascular leakage in vivo

[1]  E. Schwarz,et al.  Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice. , 2011, Arthritis and rheumatism.

[2]  S. Werner,et al.  An important role of lymphatic vessel activation in limiting acute inflammation. , 2011, Blood.

[3]  E. Kenne,et al.  Imaging inflammatory plasma leakage in vivo , 2011, Thrombosis and Haemostasis.

[4]  S. Yuan,et al.  Regulation of Endothelial Barrier Function , 2011 .

[5]  R. Jain,et al.  Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.

[6]  K. Alitalo,et al.  Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation , 2010, The Journal of experimental medicine.

[7]  Michael Detmar,et al.  Quantitative imaging of lymphatic function with liposomal indocyanine green. , 2010, Cancer research.

[8]  F. Curry,et al.  Vascular permeability modulation at the cell, microvessel, or whole organ level: towards closing gaps in our knowledge. , 2010, Cardiovascular research.

[9]  J. Levick,et al.  Microvascular fluid exchange and the revised Starling principle. , 2010, Cardiovascular research.

[10]  Arjan W. Griffioen,et al.  Imaging of angiogenesis , 2010, Angiogenesis.

[11]  S. K. Wyatt,et al.  Molecular Imaging of the Translocator Protein (TSPO) in a Pre-Clinical Model of Breast Cancer , 2010, Molecular Imaging and Biology.

[12]  M. Neeman,et al.  Visualizing vascular permeability and lymphatic drainage using labeled serum albumin , 2010, Angiogenesis.

[13]  D. Bates.  Vascular endothelial growth factors and vascular permeability , 2010, Cardiovascular research.

[14]  Eva M. Sevick-Muraca,et al.  Single-Dose Intravenous Toxicity Study of IRDye 800CW in Sprague-Dawley Rats , 2010, Molecular Imaging and Biology.

[15]  Virginia H. Huxley,et al.  Capillary Fluid Exchange: Regulation, Functions, and Pathology , 2010 .

[16]  K. Alitalo,et al.  Lymphangiogenesis: Molecular Mechanisms and Future Promise , 2010, Cell.

[17]  Jean M. J. Fréchet,et al.  Soluble Polymer Carriers for the Treatment of Cancer: The Importance of Molecular Architecture , 2010 .

[18]  Ralph Weissleder,et al.  Near-infrared fluorescence: application to in vivo molecular imaging. , 2010, Current opinion in chemical biology.

[19]  L. Ngo,et al.  The FLARE™ Intraoperative Near-Infrared Fluorescence Imaging System: A First-in-Human Clinical Trial in Breast Cancer Sentinel Lymph Node Mapping , 2009, Annals of Surgical Oncology.

[20]  Elisabetta Dejana,et al.  The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. , 2009, Developmental cell.

[21]  K. Alitalo,et al.  Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues. , 2008, The American journal of pathology.

[22]  H. Dvorak,et al.  Vascular permeability, vascular hyperpermeability and angiogenesis , 2008, Angiogenesis.

[23]  C. Beck,et al.  MRI and Quantification of Draining Lymph Node Function in Inflammatory Arthritis , 2007, Annals of the New York Academy of Sciences.

[24]  H. Dvorak,et al.  VEGF-A and the induction of pathological angiogenesis. , 2007, Annual review of pathology.

[25]  Khaled Greish,et al.  Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines , 2007, Journal of drug targeting.

[26]  Seppo Yla-Herttuala,et al.  Vascular endothelial growth factor-C accelerates diabetic wound healing. , 2006, The American journal of pathology.

[27]  M. Dewhirst,et al.  Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. , 2006, Journal of the National Cancer Institute.

[28]  Seppo Ylä-Herttuala,et al.  Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. , 2005, The Journal of clinical investigation.

[29]  D. Hicklin,et al.  Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. , 2004, Blood.

[30]  Michal Neeman,et al.  Structural, functional, and molecular MR imaging of the microvasculature. , 2003, Annual review of biomedical engineering.

[31]  Vishal Saxena,et al.  Degradation kinetics of indocyanine green in aqueous solution. , 2003, Journal of pharmaceutical sciences.

[32]  G. Yancopoulos,et al.  Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. , 2003, Blood.

[33]  Richard B Greenwald,et al.  Effective drug delivery by PEGylated drug conjugates. , 2003, Advanced drug delivery reviews.

[34]  T. Veikkola,et al.  Adenoviral VEGF‐C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  Michal Neeman,et al.  MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper‐permeability and lymphatic uptake, followed by rapid inactivation of the growth factor , 2002, NMR in biomedicine.

[36]  Thomas N. Sato,et al.  Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. , 1999, Science.

[37]  J. Isner,et al.  Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. , 1998, The American journal of pathology.

[38]  R K Jain,et al.  Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. , 1998, The Journal of investigative dermatology.

[39]  K. Alitalo,et al.  A Recombinant Mutant Vascular Endothelial Growth Factor-C that Has Lost Vascular Endothelial Growth Factor Receptor-2 Binding, Activation, and Vascular Permeability Activities* , 1998, The Journal of Biological Chemistry.

[40]  R. Jain,et al.  Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. , 1997, Science.

[41]  P Ott,et al.  Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: Comparison of spectrophotometry and high‐pressure liquid chromatography for concentration analysis , 1993, Hepatology.

[42]  C. S. Davidson,et al.  Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. , 1960, The Journal of clinical investigation.

[43]  A. A. Miles,et al.  Vascular reactions to histamine, histamine‐liberator and leukotaxine in the skin of guinea‐pigs , 1952, The Journal of physiology.

[44]  H. Wiig,et al.  Minimally invasive quantification of lymph flow in mice and rats by imaging depot clearance of near-infrared albumin. , 2012, American Journal of Physiology. Heart and Circulatory Physiology.

[45]  H. Gremlich,et al.  Fluorescent nanoprobes as a biomarker for increased vascular permeability: implications in diagnosis and treatment of cancer and inflammation. , 2010, Bioconjugate chemistry.

[46]  M. Detmar,et al.  Chapter 1. Inflammation, angiogenesis, and lymphangiogenesis. , 2008, Methods in enzymology.

[47]  Josef Machac,et al.  Clinical breast lymphoscintigraphy: optimal techniques for performing studies, image atlas, and analysis of images. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.